Cargando…
Current role of interferon in hairy cell leukemia therapy: a timely decision
Autores principales: | Silva, Wellington Fernandes da, Teixeira, Larissa Lane Cardoso, Rocha, Vanderson, Buccheri, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371201/ https://www.ncbi.nlm.nih.gov/pubmed/30793110 http://dx.doi.org/10.1016/j.htct.2018.04.004 |
Ejemplares similares
-
Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience
por: da Silva, Wellington Fernandes, et al.
Publicado: (2020) -
Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin
por: Silva, Wellington Fernandes da, et al.
Publicado: (2019) -
Time to Cure Hairy Cell Leukemia
por: Levy, Ilana, et al.
Publicado: (2017) -
Current and emerging treatment options for hairy cell leukemia
por: López-Rubio, Montserrat, et al.
Publicado: (2015) -
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects
por: Assanto, Giovanni M., et al.
Publicado: (2021)